Avelas Biosciences Secures $20,000,000 Series C Funding Round

  • Feed Type
  • Date
    8/19/2016
  • Company Name
    Avelas Biosciences
  • Mailing Address
    11099 North Torrey Pines Road La Jolla, CA 92037 USA
  • Company Description
    Avelas Biosciences develops real-time luminous maps for oncologic surgeons to refer while in surgery.
  • Website
    http://www.avelasbio.com
  • Transaction Type
    Venture Equity
  • Transaction Amount
    $20,000,000
  • Transaction Round
    Series C
  • Proceeds Purposes
    Avelas Biosciences plans to use the proceeds to advance AVB-620, a “cancer illuminator,” into late-stage clinical trials, to develop new targeted therapeutics for cancer and for general corporate purposes.
  • M&A Terms
  • Venture Investor
    Pharmstandard
  • Venture Investor
    Alexandria Venture Investments
  • Venture Investor
    Avalon Ventures
  • Venture Investor
    WuXi PharmaTech
  • Venture Investor
    Undisclosed

Trending on Xconomy